TC BioPharm Files 6-K for June 2024 Period
Ticker: TCBWF · Form: 6-K · Filed: Nov 25, 2024 · CIK: 1872812
Sentiment: neutral
Topics: regulatory-filing, corporate-information, biotech
TL;DR
TC BioPharm filed its 6-K for the June 30, 2024 period, updating corporate info. Nothing major, just housekeeping.
AI Summary
TC BioPharm (Holdings) plc, incorporated in Scotland, filed a Form 6-K on November 25, 2024, reporting for the period ending June 30, 2024. The company, previously known as TC BioPharm (Holdings) Ltd and TC BioPharm Ltd, is involved in the biological products sector. Its principal executive offices are located in Holytown, Scotland.
Why It Matters
This filing provides an update on TC BioPharm's reporting status and corporate information, which is crucial for investors tracking the company's regulatory compliance and operational details.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer information and does not contain significant financial or operational disclosures that would indicate immediate risk.
Key Numbers
- 001-41231 — SEC File Number (Identifies the company's registration with the SEC.)
Key Players & Entities
- TC BioPharm (Holdings) plc (company) — Registrant
- TC BioPharm (Holdings) Ltd (company) — Former company name
- TC BioPharm Ltd (company) — Former company name
- 20241125 (date) — Filing date
- 20240630 (date) — Reporting period end date
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information required to be made public by the registrant in its home country or filed with its home country exchange.
When was TC BioPharm (Holdings) plc incorporated or organized?
The filing states the company is incorporated in Scotland.
What were the previous names of TC BioPharm (Holdings) plc?
The company was formerly known as TC BioPharm (Holdings) Ltd, with a name change date of July 21, 2021, and prior to that, TC BioPharm Ltd, with a name change date of July 14, 2021.
What is the principal executive office address of TC BioPharm (Holdings) plc?
The principal executive offices are located at Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR, Scotland, United Kingdom.
Does TC BioPharm (Holdings) plc file annual reports under Form 20-F or 40-F?
Yes, the registrant indicates it files annual reports under cover of Form 20-F.
Filing Stats: 382 words · 2 min read · ~1 pages · Grade level 12.3 · Accepted 2024-11-25 16:05:58
Filing Documents
- form6-k.htm (6-K) — 34KB
- ex99-1.htm (EX-99.1) — 821KB
- ex99-2.htm (EX-99.2) — 182KB
- 0001493152-24-047610.txt ( ) — 5679KB
- tcbp-20240630.xsd (EX-101.SCH) — 41KB
- tcbp-20240630_cal.xml (EX-101.CAL) — 52KB
- tcbp-20240630_def.xml (EX-101.DEF) — 168KB
- tcbp-20240630_lab.xml (EX-101.LAB) — 320KB
- tcbp-20240630_pre.xml (EX-101.PRE) — 268KB
- form6-k_htm.xml (XML) — 835KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TC BIOPHARM (HOLDINGS) PLC By: /s/ Bryan Kobel Bryan Kobel Chief Executive Officer By: /s/ Martin Thorp Martin Thorp Chief Financial Officer Date: November 25, 2024 4